ACC Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis Guideline Summary - Guideline Central

Design and created by Guideline Central in participation with the American College of Cardiology.

Document Overview

Document Title: Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

Authoring Society: American College of Cardiology

Document Publication Date: Jan 23, 2023

Page Last Reviewed/Updated: May 5, 2026

Document Type: Consensus Statement

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: www.jacc.org/doi/10.1016/j.jacc.2022.11.022

Source Citation: Kittleson M, Ruberg F, et al. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis. J Am Coll Cardiol. null2023, 0 (0) .https://doi.org/10.1016/j.jacc.2022.11.022

Supplemental Implementation Resources

Document Scope, Criteria, and Use Cases

Document Objectives: With these points in mind, the purpose of this ECDP is to provide practical and timely guidance on the diagnosis and management of cardiac amyloidosis with an emphasis on the pitfalls in diagnosis and the role of multidisciplinary collaboration in optimizing management.

Scope: Assessment and Screening, Diagnosis, Management

Diseases/Conditions (MeSH)

D000686 - Amyloidosis

D000686 - Amyloidosis

Keywords: AL-CM, ATTRv-CM, cardiac amyloidosis, heart failure

Target Patient Population: Patients with or at risk for cardiac amyloidosis.

Inclusion Criteria: Male, Female, Adult, Older Adult

Health Care Settings: Ambulatory, Laboratory Services

Intended Users: Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents: 239

Includes peer/external review process?: Yes

Includes public comment process?: No

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses conflicts of interest?: Yes

Includes benefits/harms analysis with recommendations?: No